MDC - Biolab - Hormonal Women Module
Overview
MDC - Biolab - Women Hormonal Module is a structured set of hormone-related markers intended for wellness monitoring and personal health tracking. It focuses on key signals involved in female endocrine physiology, including ovarian, pituitary, and adrenal-related markers. The results are typically most meaningful when considered alongside cycle timing, lifestyle factors, and professional interpretation.
Primary focus: hormonal balance context
The module includes Estradiol and Progesterone (luteal phase only), which are commonly used to contextualize cycle-phase patterns. LH and FSH are included to provide additional information about pituitary signaling that relates to cycle dynamics. Together, these markers can support a more complete, phase-aware view of hormonal balance over time.
Androgen and binding context
Total Testosterone and DHEA-S are included to provide context around androgen-related physiology. SHBG is included as a binding marker that can help contextualize hormone availability rather than only total levels. This combination can be useful for building a more nuanced picture when reviewing results with a clinician.
Additional marker: prolactin
Prolactin is included as a supporting marker that can be relevant when reviewing broader endocrine patterns. Because prolactin can vary with factors such as stress, sleep, and timing, consistent sampling conditions can improve comparability. This marker is best interpreted in context rather than in isolation.
How to use results responsibly
Hormone markers can fluctuate based on cycle day, time of day, recent exercise, and other lifestyle variables. For Progesterone, the note “luteal phase only” highlights the importance of timing for meaningful interpretation. This module is intended for informational tracking and should be discussed with a qualified healthcare professional for individualized guidance.
| Class | Ingredient | Quantity | NRV% |
|---|---|---|---|
| Female Hormonal Axis | Estradiol (sensitive assay) | 1.0 Einheit(en) | 0.0 |
| Female Hormonal Axis | SHBG | 1.0 Einheit(en) | 0.0 |
| Female Hormonal Axis | Total Testosterone | 1.0 Einheit(en) | 0.0 |
| Female Hormonal Axis | LH | 1.0 Einheit(en) | 0.0 |
| Female Hormonal Axis | FSH | 1.0 Einheit(en) | 0.0 |
| Female Hormonal Axis | Prolactin | 1.0 Einheit(en) | 0.0 |
| Female Hormonal Axis | Progesterone (luteal phase only) | 1.0 Einheit(en) | 0.0 |
Capsules Ingredients:
Allergens:
| Title | Description |
|---|---|
| Pregnancy – Medium Risk | Hormone marker interpretation and testing timing may require specific clinical guidance during pregnancy. |
| Breastfeeding – Medium Risk | Hormonal physiology changes during breastfeeding can affect results and should be interpreted with professional support. |
| Known endocrine disorders – Medium Risk | Conditions affecting pituitary, ovarian, adrenal, or thyroid function can change these markers and warrant clinician-led interpretation. |
| Recent hormonal contraception or HRT use – Medium Risk | Exogenous hormones can significantly alter estradiol, progesterone, gonadotropins, and SHBG, affecting comparability over time. |
| Title | Description |
|---|---|
| Blood draw discomfort – Low Risk | Sample collection may cause brief pain, bruising, or tenderness at the puncture site. |
| Lightheadedness – Low Risk | Some individuals may feel faint during or after sample collection, especially if fasting or anxious. |
| Local irritation – Low Risk | Mild redness or swelling can occur at the collection site and typically resolves quickly. |
| Title | Description |
|---|---|
| Hormonal contraceptives – Medium Risk | These can alter estradiol, progesterone, LH/FSH, SHBG, and androgen markers, influencing interpretation. |
| Hormone replacement therapy (HRT) – Medium Risk | Exogenous estrogen or progesterone can change measured levels and should be disclosed for accurate context. |
| Androgen therapy or anti-androgens – Medium Risk | Medications affecting testosterone or androgen pathways can influence Total Testosterone, SHBG, and DHEA-S results. |
| Dopamine agonists/antagonists – Medium Risk | Some medicines can affect prolactin levels and may impact result interpretation. |
| Title | Description |
|---|---|
| General supplement warning – Low Risk | Food supplements should not be used as a substitute for a varied and balanced diet and a healthy lifestyle. |
| Daily dose warning – Low Risk | Do not exceed the recommended daily intake. |
| Children warning – Low Risk | Keep out of reach of young children. |
| Pregnancy and breastfeeding guidance – Medium Risk | If pregnant or breastfeeding, seek professional advice before using hormone-related testing or interpreting results. |
| Medication disclosure warning – Medium Risk | If you use prescription medicines (especially hormonal therapies), inform your healthcare professional as results may be affected. |
| Manufacturing trace warning – Low Risk | May contain very small amounts of allergens due to shared production equipment, even when not present in the ingredient list. |
| Title | Description | Bioavailability |
|---|---|---|
| Estradiol | Measured marker used to provide context on estrogen status within endocrine wellness tracking. | Not applicable (biomarker measurement; not a supplement ingredient). |
| SHBG | Measured binding marker used to contextualize hormone availability in wellness monitoring. | Not applicable (biomarker measurement; not a supplement ingredient). |
| Total Testosterone | Measured marker used to provide context on total androgen status in endocrine tracking. | Not applicable (biomarker measurement; not a supplement ingredient). |
| LH | Measured pituitary marker used to contextualize cycle-related signaling patterns. | Not applicable (biomarker measurement; not a supplement ingredient). |
| FSH | Measured pituitary marker used to contextualize follicular development signaling patterns. | Not applicable (biomarker measurement; not a supplement ingredient). |
| Prolactin | Measured marker used to provide additional endocrine context in wellness monitoring. | Not applicable (biomarker measurement; not a supplement ingredient). |
| DHEA-S | Measured adrenal-related marker used to contextualize androgen precursor status in tracking. | Not applicable (biomarker measurement; not a supplement ingredient). |
| Progesterone (luteal phase only) | Measured marker used to contextualize luteal-phase progesterone patterns in cycle-aware tracking. | Not applicable (biomarker measurement; not a supplement ingredient). |
| Allergen | Source Ingredient | Mandatory | Inference |
|---|---|---|---|
| None | None | No | None |
Population & target users: Adults 18+, intended for women seeking cycle-aware hormone marker monitoring; not intended for children. How to take: Use as directed by the testing provider/healthcare professional; follow any instructions regarding timing (e.g., luteal phase for progesterone) and whether fasting is required. Duration of use: Use as a one-time assessment or repeat at intervals recommended by a healthcare professional for trend tracking. Storage & conservation: Store any provided materials according to the kit/provider instructions; keep at room temperature unless otherwise specified and keep out of reach of children.
Vorteile
Hormonal Balance
This module is designed for women who want structured insight into hormone-related wellness patterns by tracking markers such as Estradiol, Progesterone (luteal phase only), LH, and FSH. It can be used alongside lifestyle logging (cycle timing, sleep, training load) to support more informed conversations with a healthcare professional. The inclusion of SHBG, Total Testosterone, and DHEA-S helps provide additional context around androgen balance and hormone binding.
Women's Health
This panel-style module supports women’s health monitoring by including key reproductive and adrenal-related markers such as Prolactin and DHEA-S. It may be used as part of a broader wellness check-in to understand how internal signals align with day-to-day wellbeing. Results are typically most useful when interpreted with cycle phase context, especially for Progesterone (luteal phase only).
Reproductive Health
The combination of LH, FSH, Estradiol, and Progesterone (luteal phase only) is commonly used to contextualize reproductive-cycle physiology. This can support personal tracking goals such as understanding cycle phase patterns and variability over time. SHBG and Total Testosterone add supporting context for hormone availability and balance.
Menstrual Health
Because several markers vary across the menstrual cycle (notably Estradiol, LH, FSH, and Progesterone), this module can be used to support cycle-aware wellness tracking. It may help users align testing timing with personal goals (e.g., follicular vs luteal phase context). Interpretation is best done with attention to sampling day and any relevant lifestyle factors.
Mood Support
Some people choose to track hormones such as Estradiol, Progesterone, and Prolactin when exploring how internal changes may coincide with subjective wellbeing. This module can be used as a neutral data point alongside journaling of stress, sleep, and mood patterns. It does not assess mental health status and should be interpreted by a qualified professional when needed.
